Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish Regions
Purpose The Spanish Society of Medical Oncology (SEOM) has conducted a study on the access to oncologic drugs across the 17 Spanish Regions with the aim of identifying potential heterogeneities and making proposals for eliminating the barriers identified at the different levels. Methods An Expert Pa...
Gespeichert in:
| Veröffentlicht in: | Clinical & translational oncology 2017-03, Vol.19 (3), p.341-356 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 356 |
|---|---|
| container_issue | 3 |
| container_start_page | 341 |
| container_title | Clinical & translational oncology |
| container_volume | 19 |
| creator | Salvador, J. Urtasun, J. A. Duart, F. J. B. García-Campelo, R. Carbonero, R. G. Lianes, P. Llombart, A. Casado, D. I. Piera, J. M. Mateu, M. M. Puente, J. Rivera, F. Rodríguez, C. A. Virizuela, J. A. Martín, M. Garrido, P. |
| description | Purpose
The Spanish Society of Medical Oncology (SEOM) has conducted a study on the access to oncologic drugs across the 17 Spanish Regions with the aim of identifying potential heterogeneities and making proposals for eliminating the barriers identified at the different levels.
Methods
An Expert Panel made up of medical oncologists designed a survey on certain indications approved for 11 drugs in the approach of breast cancer, melanoma, lung cancer, prostate cancer and support treatment. This survey was sent to 144 National Health System (NHS) hospitals.
Results
77 hospitals answered the survey. The information modules analysed were: scope of the Commission that establishes binding decisions related to drug access; conditions, stages and periods of drug application, approval and administration processes; barriers to accessing drugs.
Conclusions
The study shows variability in drug access. The SEOM makes proposals addressed to reducing the differences identified and homogenizing drug access conditions. |
| doi_str_mv | 10.1007/s12094-016-1535-8 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5306184</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1859716656</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-abe2aaff7100d30a4afd70b331cd2fa3f352ffc26e41f862e966fb49c5b325693</originalsourceid><addsrcrecordid>eNp9kc1u1DAUhSMEoj_wAGyQlywI-Cd2EhZIVdUCUlElChI7y7GvM64y9tQ3QZrH4I1xZ4aKbljZOufcY-t-VfWK0XeM0vY9Mk77pqZM1UwKWXdPqmOm-r4WVMqnhzttup9H1QniLS2qYux5dcRbqbhg_Lj6fXG3hHn7lgwm5wAZiYmOWBMtZOICbkwOcwD8QHBe3JYkT-YVkJuNiQFX5CbZAPNO_gouWDOR62jTlMaixV3UWAuIZE5F2DnBEpeXEUmIj7q-wRhSxBfVM28mhJeH87T6cXnx_fxzfXX96cv52VVtm4bPtRmAG-N9WzbhBDWN8a6lgxDMOu6N8EJy7y1X0DDfKQ69Un5oeisHwaXqxWn1cd-7WYY1OAtxzmbSmxzWJm91MkE_dmJY6TH90lJQxbqmFLw5FOR0twDOeh3QwjSZCGlBzTrZt0wpqUqU7aM2J8QM_uEZRvU9Sr1HqQtKfY9Sd2Xm9b__e5j4y64E-D6AxYojZH2blhzLzv7T-gezEq2F</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1859716656</pqid></control><display><type>article</type><title>Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish Regions</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Salvador, J. ; Urtasun, J. A. ; Duart, F. J. B. ; García-Campelo, R. ; Carbonero, R. G. ; Lianes, P. ; Llombart, A. ; Casado, D. I. ; Piera, J. M. ; Mateu, M. M. ; Puente, J. ; Rivera, F. ; Rodríguez, C. A. ; Virizuela, J. A. ; Martín, M. ; Garrido, P.</creator><creatorcontrib>Salvador, J. ; Urtasun, J. A. ; Duart, F. J. B. ; García-Campelo, R. ; Carbonero, R. G. ; Lianes, P. ; Llombart, A. ; Casado, D. I. ; Piera, J. M. ; Mateu, M. M. ; Puente, J. ; Rivera, F. ; Rodríguez, C. A. ; Virizuela, J. A. ; Martín, M. ; Garrido, P.</creatorcontrib><description>Purpose
The Spanish Society of Medical Oncology (SEOM) has conducted a study on the access to oncologic drugs across the 17 Spanish Regions with the aim of identifying potential heterogeneities and making proposals for eliminating the barriers identified at the different levels.
Methods
An Expert Panel made up of medical oncologists designed a survey on certain indications approved for 11 drugs in the approach of breast cancer, melanoma, lung cancer, prostate cancer and support treatment. This survey was sent to 144 National Health System (NHS) hospitals.
Results
77 hospitals answered the survey. The information modules analysed were: scope of the Commission that establishes binding decisions related to drug access; conditions, stages and periods of drug application, approval and administration processes; barriers to accessing drugs.
Conclusions
The study shows variability in drug access. The SEOM makes proposals addressed to reducing the differences identified and homogenizing drug access conditions.</description><identifier>ISSN: 1699-048X</identifier><identifier>EISSN: 1699-3055</identifier><identifier>DOI: 10.1007/s12094-016-1535-8</identifier><identifier>PMID: 27562312</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Antineoplastic Agents - therapeutic use ; Health Services Accessibility ; Healthcare Disparities ; Humans ; Medical Oncology ; Medicine ; Medicine & Public Health ; Neoplasms - drug therapy ; Oncology ; Research Article ; Societies, Medical ; Surveys and Questionnaires</subject><ispartof>Clinical & translational oncology, 2017-03, Vol.19 (3), p.341-356</ispartof><rights>Federación de Sociedades Españolas de Oncología (FESEO) 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-abe2aaff7100d30a4afd70b331cd2fa3f352ffc26e41f862e966fb49c5b325693</citedby><cites>FETCH-LOGICAL-c442t-abe2aaff7100d30a4afd70b331cd2fa3f352ffc26e41f862e966fb49c5b325693</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12094-016-1535-8$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12094-016-1535-8$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27562312$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Salvador, J.</creatorcontrib><creatorcontrib>Urtasun, J. A.</creatorcontrib><creatorcontrib>Duart, F. J. B.</creatorcontrib><creatorcontrib>García-Campelo, R.</creatorcontrib><creatorcontrib>Carbonero, R. G.</creatorcontrib><creatorcontrib>Lianes, P.</creatorcontrib><creatorcontrib>Llombart, A.</creatorcontrib><creatorcontrib>Casado, D. I.</creatorcontrib><creatorcontrib>Piera, J. M.</creatorcontrib><creatorcontrib>Mateu, M. M.</creatorcontrib><creatorcontrib>Puente, J.</creatorcontrib><creatorcontrib>Rivera, F.</creatorcontrib><creatorcontrib>Rodríguez, C. A.</creatorcontrib><creatorcontrib>Virizuela, J. A.</creatorcontrib><creatorcontrib>Martín, M.</creatorcontrib><creatorcontrib>Garrido, P.</creatorcontrib><title>Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish Regions</title><title>Clinical & translational oncology</title><addtitle>Clin Transl Oncol</addtitle><addtitle>Clin Transl Oncol</addtitle><description>Purpose
The Spanish Society of Medical Oncology (SEOM) has conducted a study on the access to oncologic drugs across the 17 Spanish Regions with the aim of identifying potential heterogeneities and making proposals for eliminating the barriers identified at the different levels.
Methods
An Expert Panel made up of medical oncologists designed a survey on certain indications approved for 11 drugs in the approach of breast cancer, melanoma, lung cancer, prostate cancer and support treatment. This survey was sent to 144 National Health System (NHS) hospitals.
Results
77 hospitals answered the survey. The information modules analysed were: scope of the Commission that establishes binding decisions related to drug access; conditions, stages and periods of drug application, approval and administration processes; barriers to accessing drugs.
Conclusions
The study shows variability in drug access. The SEOM makes proposals addressed to reducing the differences identified and homogenizing drug access conditions.</description><subject>Antineoplastic Agents - therapeutic use</subject><subject>Health Services Accessibility</subject><subject>Healthcare Disparities</subject><subject>Humans</subject><subject>Medical Oncology</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Neoplasms - drug therapy</subject><subject>Oncology</subject><subject>Research Article</subject><subject>Societies, Medical</subject><subject>Surveys and Questionnaires</subject><issn>1699-048X</issn><issn>1699-3055</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><recordid>eNp9kc1u1DAUhSMEoj_wAGyQlywI-Cd2EhZIVdUCUlElChI7y7GvM64y9tQ3QZrH4I1xZ4aKbljZOufcY-t-VfWK0XeM0vY9Mk77pqZM1UwKWXdPqmOm-r4WVMqnhzttup9H1QniLS2qYux5dcRbqbhg_Lj6fXG3hHn7lgwm5wAZiYmOWBMtZOICbkwOcwD8QHBe3JYkT-YVkJuNiQFX5CbZAPNO_gouWDOR62jTlMaixV3UWAuIZE5F2DnBEpeXEUmIj7q-wRhSxBfVM28mhJeH87T6cXnx_fxzfXX96cv52VVtm4bPtRmAG-N9WzbhBDWN8a6lgxDMOu6N8EJy7y1X0DDfKQ69Un5oeisHwaXqxWn1cd-7WYY1OAtxzmbSmxzWJm91MkE_dmJY6TH90lJQxbqmFLw5FOR0twDOeh3QwjSZCGlBzTrZt0wpqUqU7aM2J8QM_uEZRvU9Sr1HqQtKfY9Sd2Xm9b__e5j4y64E-D6AxYojZH2blhzLzv7T-gezEq2F</recordid><startdate>20170301</startdate><enddate>20170301</enddate><creator>Salvador, J.</creator><creator>Urtasun, J. A.</creator><creator>Duart, F. J. B.</creator><creator>García-Campelo, R.</creator><creator>Carbonero, R. G.</creator><creator>Lianes, P.</creator><creator>Llombart, A.</creator><creator>Casado, D. I.</creator><creator>Piera, J. M.</creator><creator>Mateu, M. M.</creator><creator>Puente, J.</creator><creator>Rivera, F.</creator><creator>Rodríguez, C. A.</creator><creator>Virizuela, J. A.</creator><creator>Martín, M.</creator><creator>Garrido, P.</creator><general>Springer International Publishing</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20170301</creationdate><title>Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish Regions</title><author>Salvador, J. ; Urtasun, J. A. ; Duart, F. J. B. ; García-Campelo, R. ; Carbonero, R. G. ; Lianes, P. ; Llombart, A. ; Casado, D. I. ; Piera, J. M. ; Mateu, M. M. ; Puente, J. ; Rivera, F. ; Rodríguez, C. A. ; Virizuela, J. A. ; Martín, M. ; Garrido, P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-abe2aaff7100d30a4afd70b331cd2fa3f352ffc26e41f862e966fb49c5b325693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Antineoplastic Agents - therapeutic use</topic><topic>Health Services Accessibility</topic><topic>Healthcare Disparities</topic><topic>Humans</topic><topic>Medical Oncology</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Neoplasms - drug therapy</topic><topic>Oncology</topic><topic>Research Article</topic><topic>Societies, Medical</topic><topic>Surveys and Questionnaires</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Salvador, J.</creatorcontrib><creatorcontrib>Urtasun, J. A.</creatorcontrib><creatorcontrib>Duart, F. J. B.</creatorcontrib><creatorcontrib>García-Campelo, R.</creatorcontrib><creatorcontrib>Carbonero, R. G.</creatorcontrib><creatorcontrib>Lianes, P.</creatorcontrib><creatorcontrib>Llombart, A.</creatorcontrib><creatorcontrib>Casado, D. I.</creatorcontrib><creatorcontrib>Piera, J. M.</creatorcontrib><creatorcontrib>Mateu, M. M.</creatorcontrib><creatorcontrib>Puente, J.</creatorcontrib><creatorcontrib>Rivera, F.</creatorcontrib><creatorcontrib>Rodríguez, C. A.</creatorcontrib><creatorcontrib>Virizuela, J. A.</creatorcontrib><creatorcontrib>Martín, M.</creatorcontrib><creatorcontrib>Garrido, P.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical & translational oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Salvador, J.</au><au>Urtasun, J. A.</au><au>Duart, F. J. B.</au><au>García-Campelo, R.</au><au>Carbonero, R. G.</au><au>Lianes, P.</au><au>Llombart, A.</au><au>Casado, D. I.</au><au>Piera, J. M.</au><au>Mateu, M. M.</au><au>Puente, J.</au><au>Rivera, F.</au><au>Rodríguez, C. A.</au><au>Virizuela, J. A.</au><au>Martín, M.</au><au>Garrido, P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish Regions</atitle><jtitle>Clinical & translational oncology</jtitle><stitle>Clin Transl Oncol</stitle><addtitle>Clin Transl Oncol</addtitle><date>2017-03-01</date><risdate>2017</risdate><volume>19</volume><issue>3</issue><spage>341</spage><epage>356</epage><pages>341-356</pages><issn>1699-048X</issn><eissn>1699-3055</eissn><abstract>Purpose
The Spanish Society of Medical Oncology (SEOM) has conducted a study on the access to oncologic drugs across the 17 Spanish Regions with the aim of identifying potential heterogeneities and making proposals for eliminating the barriers identified at the different levels.
Methods
An Expert Panel made up of medical oncologists designed a survey on certain indications approved for 11 drugs in the approach of breast cancer, melanoma, lung cancer, prostate cancer and support treatment. This survey was sent to 144 National Health System (NHS) hospitals.
Results
77 hospitals answered the survey. The information modules analysed were: scope of the Commission that establishes binding decisions related to drug access; conditions, stages and periods of drug application, approval and administration processes; barriers to accessing drugs.
Conclusions
The study shows variability in drug access. The SEOM makes proposals addressed to reducing the differences identified and homogenizing drug access conditions.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>27562312</pmid><doi>10.1007/s12094-016-1535-8</doi><tpages>16</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1699-048X |
| ispartof | Clinical & translational oncology, 2017-03, Vol.19 (3), p.341-356 |
| issn | 1699-048X 1699-3055 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5306184 |
| source | MEDLINE; Springer Nature - Complete Springer Journals |
| subjects | Antineoplastic Agents - therapeutic use Health Services Accessibility Healthcare Disparities Humans Medical Oncology Medicine Medicine & Public Health Neoplasms - drug therapy Oncology Research Article Societies, Medical Surveys and Questionnaires |
| title | Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish Regions |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-20T19%3A07%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Equity,%20barriers%20and%20cancer%20disparities:%20study%20of%20the%20Spanish%20Society%20of%20Medical%20Oncology%20on%20the%20access%20to%20oncologic%20drugs%20in%20the%20Spanish%20Regions&rft.jtitle=Clinical%20&%20translational%20oncology&rft.au=Salvador,%20J.&rft.date=2017-03-01&rft.volume=19&rft.issue=3&rft.spage=341&rft.epage=356&rft.pages=341-356&rft.issn=1699-048X&rft.eissn=1699-3055&rft_id=info:doi/10.1007/s12094-016-1535-8&rft_dat=%3Cproquest_pubme%3E1859716656%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1859716656&rft_id=info:pmid/27562312&rfr_iscdi=true |